Get started
MEDIBANK PRIVATE LIMITEDMEDIBANK PRIVATE LIMITEDMEDIBANK PRIVATE LIMITED

MEDIBANK PRIVATE LIMITED

No trades
See on Supercharts
Overview
Financials News Ideas Discussions Technicals Forecast Seasonals

MPL chart


Full chart

MPL upcoming earnings

Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—

Key stats


Market capitalization
‪10.41 B‬ AUD
Dividend yield (indicated)
4.41%
Price to earnings Ratio (TTM)
21.14
Basic EPS (TTM)
0.18 AUD
Net income (FY)
‪492.50 M‬ AUD
Revenue (FY)
‪8.02 B‬ AUD
Shares float
‪2.75 B‬
Beta (1Y)
0.52

Employees


Employees (FY)
‪3.22 K‬
Change (1Y)
−22 −0.68%
Revenue / Employee (1Y)
‪2.49 M‬ AUD
Net income / Employee (1Y)
‪152.95 K‬ AUD

About MEDIBANK PRIVATE LIMITED


Sector
Finance
Industry
Life/Health Insurance
CEO
David Koczkar
Website
medibank.com.au
Headquarters
Docklands
Founded
1976
ISIN
AU000000MPL3
FIGI
BBG000BL8N65
Medibank Private Ltd. engages in the underwriting and distribution of private health insurance policies. It operates through the Health Insurance and Medibank Health segments.The Health Insurance segment offers private health insurance products including hospital cover and ancillary cover, as stand-alone products and packaged products. The Medibank Health segment refers to a range of activities including contracting with government and corporate customers to provide health management services, as well as providing a range of telehealth services in Australia. The company was founded in 1976 and is headquartered in Docklands, Australia.

Financials


Performance
Revenue to profit conversion
Insurance reserves, claims and premiums
Earnings
Next:—

MPL news



Ideas



See all ideas 

Technicals

Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Analyst rating


An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

Frequently Asked Questions


The current price of MPL is 3.76 AUD — it has decreased by −0.53% in the past 24 hours. Watch MEDIBANK PRIVATE LIMITED stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on ASX exchange MEDIBANK PRIVATE LIMITED stocks are traded under the ticker MPL.
MPL stock has risen by 1.08% compared to the previous week, the month change is a −0.79% fall, over the last year MEDIBANK PRIVATE LIMITED has showed a 5.62% increase.
We've gathered analysts' opinions on MEDIBANK PRIVATE LIMITED future price: according to them, MPL price has a max estimate of 4.55 AUD and a min estimate of 3.80 AUD. Watch MPL chart and read a more detailed MEDIBANK PRIVATE LIMITED stock forecast: see what analysts think of MEDIBANK PRIVATE LIMITED and suggest that you do with its stocks.
MPL reached its all-time high on Sep 3, 2024 with the price of 4.01 AUD, and its all-time low was 1.99 AUD and was reached on Aug 18, 2015. View more price dynamics on MPL chart.
See other stocks reaching their highest and lowest prices.
MPL stock is 1.07% volatile and has beta coefficient of 0.52. Track MEDIBANK PRIVATE LIMITED stock price on the chart and check out the list of the most volatile stocks — is MEDIBANK PRIVATE LIMITED there?
Yes, you can track MEDIBANK PRIVATE LIMITED financials in yearly and quarterly reports right on TradingView.
MEDIBANK PRIVATE LIMITED is going to release the next earnings report on Feb 27, 2025. Keep track of upcoming events with our Earnings Calendar.
MPL earnings for the last half-year are 0.11 AUD per share, whereas the estimation was 0.10 AUD, resulting in a 10.13% surprise. The estimated earnings for the next half-year are 0.10 AUD per share. See more details about MEDIBANK PRIVATE LIMITED earnings.
MEDIBANK PRIVATE LIMITED revenue for the last half-year amounts to ‪4.15 B‬ AUD, despite the estimated figure of ‪4.16 B‬ AUD. In the next half-year revenue is expected to reach ‪4.25 B‬ AUD.
MPL net income for the last half-year is ‪149.30 M‬ AUD, while the previous report showed ‪343.20 M‬ AUD of net income which accounts for −56.50% change. Track more MEDIBANK PRIVATE LIMITED financial stats to get the full picture.
MEDIBANK PRIVATE LIMITED dividend yield was 4.45% in 2024, and payout ratio reached 92.84%. The year before the numbers were 4.15% and 130.24% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
As of Dec 22, 2024, the company has ‪3.22 K‬ employees. See our rating of the largest employees — is MEDIBANK PRIVATE LIMITED on this list?
Like other stocks, MPL shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade MEDIBANK PRIVATE LIMITED stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So MEDIBANK PRIVATE LIMITED technincal analysis shows the neutral today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating MEDIBANK PRIVATE LIMITED stock shows the buy signal. See more of MEDIBANK PRIVATE LIMITED technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.